Euro-Sante :: Euro-Health

The relevance of value in establishing the positioning of medicines is the new normal for pharmaceutical marketing. Pharmaceutical companies have customers who are highly constrained by whether healthcare system funding is sustainable long term. Remember, payers think epidemiologically and in multiple years of costed care so industry needs to assess how that can be understood […]

Posted by Mike Tremblay

The AI agenda is for me all about augmenting human reasoning; what I call cognology (cognitive focus) to distinguish from technology (physical focus). This is the core challenge to work flow and adoption. Here are some thoughts on the application of John Boyd’s OODA decision making from military decision making to healthcare decision making. Boyd […]

Posted by Mike Tremblay

From the UK Guardian: private healthcare providers. The research on comparative performance of for profit and not for profit healthcare providers is well developed, so it is surprising to see such a weak quality assessment about private providers in the NHS. The NHS is a very difficult customer for a number of reasons, primarily the glass […]

Posted by Mike Tremblay

Dr Tim Oliver posted on the LSE Blog a thoughtful item on the various ways to understand the negotiation structure of Brexit [link to item] He puts forward four key ones, and what I want to do is briefly comment on each. Neoclassical Realism: This is about power relationships. The UK’s position within the EU […]

Posted by Mike Tremblay

A central feature of any high performing healthcare system or organisation includes best practice in medicines use and management. As all aspects of healthcare are under varying degrees of financial stress these days, cost controls and appropriate use of medicines must support the highest standards of clinical practice and safe patient care. Medicines optimisation is one strategy as the use of medicines influences the quality of healthcare across the whole patient treatment pathway. Failure to optimise the use of medicines across this pathway may arise from: misuse of medicines (failure to prescribe when appropriate, prescribing when not appropriate, prescribing the wrong medicine, failure to reconcile medicines use across clinical hand-offs; “clinical inertia” and failure to manage patients to goal (e.g. management of diabetes, and hypertension post aMI) [O’Connor PJ, SperlHillen JM, Johnson PE, Rush WA, Blitz WAR, Clinical inertia and outpatient medical errors, in Henriksen K, Battles JB, Marks ES et al, editors, Advances in Patient Safety: From Research to Implementation Vol 2: Concepts and Methodology), Agency for Healthcare Research and Quality, 2005]; failure to use or follow best-practice and rational prescribing guidance; lack of synchronisation between the use of medicines (demand) and procurement (supply), with an impact on inventory management and loss of cost control of the medicines budget. The essential challenge is ensuring that the healthcare system and its constituent parts are fit for purpose to address and avoid these failures or at least minimise their negative impact. Medicines costs are the fastest growing area of expenditure and comprise a major constituent of patient treatment and recovery. The cost of drug mortality was described in 1995 [Johnson JA, Bootman JL. Drug-related morbidity and mortality; a cost of illness model. Arch […]

Posted by Mike Tremblay

A central feature of any high performing healthcare system or organisation includes best practice in medicines use and management. As all aspects of healthcare are under varying degrees of financial stress these days, cost controls and appropriate use of medicines must support the highest standards of clinical practice and safe patient care. Medicines optimisation is… » read more

Posted by EuroSante

How can I be sure the medicine I take is genuine? Counterfeit medicines are a global problem, with trade in the billions of dollars. The World Health Organization estimates 8-10% of all drugs supplied globally are counterfeit. Counterfeits are a clear and present danger to human health. No country is immune from the risk. Fake […]

Posted by Mike Tremblay

The King’s Fund, a UK health charity ran a scenario essay writing competition, and here is the link and of course congratulations to the winner: (winner, runner up and other scenarios, but not mine). My scenario builds on the notion of service unbundling and draws on strong and weak signals of changes likely to impact […]

Posted by Mike Tremblay

This is a summary of some emerging and salient issues related to the UK departure from the EU. Workforce It is estimated that the UK recruits 7000 nurses and 2000 doctors annually from the EU. The UK is currently unable to meet its workforce requirements for the NHS from its domestic higher education system. To […]

Posted by Mike Tremblay